Skip to main content
Cash
Portfolio
TrendingMidtermsElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive165AccountSocial
MARKETSINVESTLIVE165
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
Series Image
  1. Medicine

Will the FDA approve cytisinicline for smoking cessation?

4


Chance

Before Jan 1, 2027
7%

Before Jan 1, 2027

7%

Before Jul 1, 2027
35%

Before Jul 1, 2027

35%

2 more

Will the FDA approve cytisinicline for smoking cessation?

Before Jan 1, 2027

Odds
11% chance
Max payout
Dec 31, 2026
$0
$14,242 vol
More Science and Technology Markets

More Will the FDA approve drug? markets

Will the FDA approve CagriSema?Will the FDA approve intismeran autogene (V940/mRNA-4157)?Will the FDA approve MDMA for PTSD?

Trending Science and Technology markets

Best AI at the end of 2026?Will the U.S. confirm that aliens exist?DeepSeek market share this weekOpenAI market share this weekGoogle market share this weekWhen will OpenAI release Astra 6.1+?Anthropic market share this weekOpen vs. Closed Token Volume (open weights share) today

Science and Technology hub

All Science and Technology markets